GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 39 filers reported holding GAMIDA CELL LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,030 | -46.6% | 1,000 | 0.0% | 0.00% | – |
| Q2 2023 | $1,930 | +138.3% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $810 | -37.2% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,290 | -35.5% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -33.3% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $6,000 | -25.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $8,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | +100.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | -20.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $5,000 | +66.7% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,287,745 | $27,584,000 | 2.58% |
| Stonepine Capital Management, LLC | 379,470 | $3,184,000 | 2.44% |
| Healthcare Value Capital, LLC | 50,000 | $420,000 | 1.42% |
| BVF INC/IL | 1,343,667 | $11,273,000 | 0.44% |
| Rock Springs Capital Management LP | 2,094,000 | $17,569,000 | 0.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 70,852 | $594,000 | 0.34% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,431,795 | $20,403,000 | 0.33% |
| Atom Investors LP | 217,231 | $1,823,000 | 0.18% |
| MYDA Advisors LLC | 56,000 | $470,000 | 0.14% |
| J. Goldman & Co LP | 314,236 | $2,636,000 | 0.13% |